Van Cutsem E, Machiels J, Van den Eynde M, Prenen H, et al. Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer. Ann Oncol 2019;30 Suppl 4:iv124-iv125.
PMID: 32085011